Drug · DIN 02467224
OCREVUS
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 21, 2017; first marketed September 21, 2017.
- Drug Identification Number (DIN)
- 02467224
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Ocrelizumab L04AG08
- Class
- Human
- Record last updated
- September 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OCRELIZUMAB | 30 MG | ML |